CDK11A

Across TCGA pan-cancer cohorts, CDK11A mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CDK11A’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where CDK11A mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types CDK11A is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

HNSC, PDAC, and LUAD are the cancer types where CDK11A tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDK11A mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.311	<.001	8	view →
PDAC	All	All	+0.225	.034	2	view →
LUAD	All	All	+0.150	.018	2	view →
COAD	Female	III,IV	−0.425	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CDK11A–HNSC

Open the HNSC breakdown →